An interventional study of Mobile-health self management in Cancer, Chemotherapy Effect and Quality of Life, sponsored by Universitas Muhammadiyah Yogyakarta. Status unknown. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2023-05-30.
Sponsored by Universitas Muhammadiyah Yogyakarta · Not applicable, Interventional, and Treatment
The study will design and evaluate the use of mobile-health based self-management on self-efficacy and quality of life of patients undergoing chemotherapy.
The study will design and evaluate the use of mobile-health based self-management on self-efficacy and quality of life of patients undergoing chemotherapy.
9,617 studies on the registry are indexed under Neoplasms; 2,508 are open to participants now.
This study's planned enrollment of 50 is close to the median of 50 across 7,432 interventional studies indexed under Neoplasms.
Browse Neoplasms studies →Universitas Muhammadiyah Yogyakarta is the lead sponsor of 7 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Behavioral: Mobile-health self management
Mobile-health self management
Patient's Quality of life
The patient's quality of life will be assessed before (T0) and after intervention (T1). The measurement will use EORTC. The score will range from 0-100, where higher score reflects a better quality of life.
Time frame: Four weeks
Patient's Self-efficacy
The patients self-efficacy will be measured pre and post intervention. The measurement will use the Self-Efficacy for Managing Chronic Disease Scale. The scale has been widely used in cancer setting. Respondents will rate their confidence to perform six self-management behaviours (1 = 'not at all confident' to 10 = 'totally confident'). A mean score is calculated (range 1 to 10). A high score indicates high self-efficacy.
Time frame: four weeks
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in May 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universitas Muhammadiyah Yogyakarta